Analystreport

Moleculin Biotech Inc (NASDAQ: MBRX) had its "buy" rating re-affirmed by analysts at Maxim Group.

Moleculin Biotech, Inc.  (MBRX) 
Last moleculin biotech, inc. earnings: 8/16 05:35 pm Check Earnings Report
US:NASDAQ Investor Relations: moleculin.com/investors